Instil Bio, Inc. — Director's Dealing 2022

May 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Instil Bio, Inc. (TIL)
CIK: 0001789769
Period of Report: 2022-05-20

Reporting Person: Gibson Neil W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-20	Employee Stock Option (right to buy)	$7.27	A	30000	Acquired	2032-05-19	Common Stock (30000.0)	Direct

Footnotes

F1: The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date.